BECTON, DICKINSON AND COMPANY (NYSE:BDX) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07.Submission of Matters to a Vote of Security Holders.
The 2018 Annual Meeting of Shareholders (“Annual Meeting”) of Becton, Dickinson and Company ("BD") was held on January23, 2018. The final results for each of the matters submitted to a vote of shareholders at the Annual Meeting are as follows:
|
Nominee |
For |
Against |
Abstain |
Broker Non-Votes |
|
Catherine M. Burzik |
181,838,712 |
396,011 |
193,110 |
22,051,642 |
|
R. Andrew Eckert |
181,397,196 |
810,263 |
220,374 |
22,051,642 |
|
Vincent A. Forlenza |
175,320,986 |
6,595,040 |
511,807 |
22,051,642 |
|
Claire M. Fraser |
180,220,018 |
1,922,077 |
215,739 |
22,051,642 |
|
Christopher Jones |
181,754,783 |
433,683 |
239,366 |
22,051,642 |
|
Marshall O. Larsen |
177,509,354 |
4,689,592 |
228,887 |
22,051,642 |
|
Gary A. Mecklenburg |
177,252,447 |
4,924,708 |
250,678 |
22,051,642 |
|
David F. Melcher |
181,395,664 |
778,179 |
253,990 |
22,051,642 |
|
Willard J. Overlock, Jr. |
175,740,608 |
6,413,574 |
273,651 |
22,051,642 |
|
Claire Pomeroy |
181,235,694 |
960,909 |
231,230 |
22,051,642 |
|
Rebecca W. Rimel |
181,323,801 |
925,961 |
178,071 |
22,051,642 |
|
Timothy M. Ring |
180,662,688 |
1,507,137 |
258,008 |
22,051,642 |
|
Bertram L. Scott |
177,363,501 |
4,809,359 |
254,973 |
22,051,642 |
ItemNo.2:The appointment of Ernst& Young as BD’s independent registered public accounting firm for fiscal year 2018 was ratified by the shareholders by the votes set forth in the table below.
|
For |
Against |
Abstain |
|
199,034,587 |
5,231,650 |
213,239 |
ItemNo.3:The shareholders approved, on an advisory, non-binding basis, the compensation of BD’s named executive officers by the votes set forth in the table below.
|
For |
Against |
Abstain |
Broker Non-Votes |
|
173,791,716 |
8,100,379 |
535,738 |
22,051,642 |
Item No. 4: A shareholder proposal regarding an amendment to the Company's proxy access by-law was not approved by the votes set forth in the table below.
|
For |
Against |
Abstain |
Broker Non-Votes |
|
50,135,096 |
131,510,881 |
781,856 |
22,051,642 |
Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company’s BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.
